News Focus
News Focus
Followers 65
Posts 27719
Boards Moderated 0
Alias Born 11/23/2016

Re: tradeherpete post# 391550

Sunday, 12/11/2022 12:33:59 PM

Sunday, December 11, 2022 12:33:59 PM

Post# of 517128
The best way to avoid lecanamab etc. that folks here hate, is that Anavex stays on goal presenting unquestionably great full TLD and an acceptable Surrogate Endpoint biomarker from the prespecified subgroup analysis.

I believe lecanemab is a scam with horrible side effects and Biogen is a disreputable company that uses illegal and improper means to make a profit off of unsuspecting, suffering people.


I guess SAVA, Synaptogenix or any other company's potentially successful and safe AD drug could fulfil that hope too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News